Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia
Completed · Phase 1 · Has a placebo group
Conditions studied: Schizophrenia
In brief
This study aims to assess the safety, tolerability and pharmacokinetics of PF-04958242 in multiple ascending doses in subjects with stable schizophrenia.
Key facts
- Study ID
- NCT02332798
- Run by
- Biogen
- People needed
- 39
- Starts
- 2015-01-06
- Expected to finish
- 2015-04-15
- Last updated by the study team
- 2021-10-25
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Collaborative Neuroscience Network, LLC. — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.